$NNOX

Suesskind Dan S purchased $46K of NNOX

Suesskind Dan S purchased 50,000 shares of Nano-X Imaging Ltd. (NNOX) at an average of $0.93 ($0.92–$0.94) across 2 trades on 2026-07-27.

Original reporting
SEC EDGAR · Suesskind Dan S
Published Jul 29, 2026, 11:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 12:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NNOX
Bullish
medium confidence
Mentioned
$NNOX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NNOXBullishLow
01

Why it matters

Traders may view the buy as a small positive signal, but without new operational or regulatory information it is unlikely to drive sustained repricing.

02

Market read

A director’s open-market purchase is newly disclosed, but it does not include any new company performance or catalyst details.

03

What to watch

The transaction size is moderate and the article provides no follow-on context (e.g., other insiders buying, changes in guidance, or material corporate events).

Relevance 4/10Novelty 5/10Timing: SEC Form 4 filed 2026-07-29 for a 2026-07-27 insider purchase

Background

The filing is an SEC Form 4 insider transaction for Nano-X Imaging Ltd., reported by director Suesskind Dan S.

Company-level read

Ticker impact

$NNOXBullishMedium confidence
Context

Director Suesskind Dan S filed a Form 4 open-market purchase of 50,000 NNOX shares at about $0.93 per share on 2026-07-27.

Expected impact

Near-term impact is likely limited; any reaction would be sentiment-driven rather than based on new operational guidance.

Evidence & confidence

The article is a primary SEC Form 4 disclosure showing an open-market purchase by a director, with no accompanying earnings, trial, contract, or regulatory update.

Market effects

No sector-wide read-across is provided; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider open-market buys can be routine or planned, and this filing notes no 10b5-1 plan, which may still reflect non-informational timing.

Key entities

  • Nano-X Imaging Ltd.

    Subject of the Form 4 insider purchase disclosure.

  • Suesskind Dan S

    Director who purchased 50,000 shares in open-market trades at ~$0.93 average price.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NNOXMed

NANO-X IMAGING LTD: Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

Nanox Imaging Ltd (NASDAQ: NNOX) said its subsidiary Nanox AI entered an exclusive UK sales reseller agreement with Vertec Scientific for commercialization of Nanox.AI bone solution (HealthOST). The initial three-year term requires Vertec to meet minimum annual license commitments. HealthOST is FDA-cleared and UKCA/CE-marked and was recommended by NICE in Nov 2025 for NHS use.